ProfileGDS4459 / ENSG00000148384
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 57% 50% 49% 50% 52% 54% 49% 50% 45% 52% 38% 45% 51% 35% 48% 44% 35% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.6557
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.3950
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.3249
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.5150
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.4552
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.5454
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.3749
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.3450
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.1945
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.5252
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.8738
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.1645
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.4651
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.9535
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.2948
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.2244
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.9135